Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody (HRP) was raised against a peptide corresponding to 10 amino acids near the amino terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein. The immunogen is located within the first 50 amino acids of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope.
Conjugation:
HRP
Alternative Names:
2019-nCoV) Envelope Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), E protein, Envelope protein, SARS-CoV-2 (COVID-19, covid-19, sars-cov-2
SARS-CoV-2 (COVID-19) Envelope Antibody is supplied in PBS containing 0.02% sodium azide.
Form:
Liquid
Target:
E
Application Notes:
Application Notes: IHC: 2 µg/mL Antibody validated: Immunohistochemistry in COVID-19 patient samples. All other applications and species not yet tested
Immunohistochemistry Validation of SARS-CoV-2 (COVID-19) Envelope Protein in COVID-19 Patient Lung. Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 (COVID-19) envelope antibody (orb1239043, 2 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT, antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 C. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 envelope protein was observed in macrophages of COVID-19 patient lung, but not in non-COVID-19 patient lung.
ELISA Validation. Coating Antigen: immunogen peptide, orb1236593, 10 ug/mL, incubate at 4 C overnight. Detection Antibodies: SARS-CoV-2 Spike antibody, orb1239043 or orb1239971, dilution: 0.5-1000 ng/mL, incubate at RT for 1 hr. orb1239971 was detected by anti-rabbit HRP-conjugated secondary antibodies at 1:10000, incubate at RT for 1 hr.
* VAT and and shipping costs not included. Errors and price changes excepted
